Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
The information required in the remainder of this cover
page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13G
|
|
|
CUSIP No. 761330109
|
|
Page 2 of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures V,
L.L.C.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
457,085
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
457,085
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
457,085
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
1.25%
|
12
|
|
TYPE OF REPORTING
PERSON
OO
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
3
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures
Fund V, L.P.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
457,085
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
457,085
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
457,085
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
1.25%
|
12
|
|
TYPE OF REPORTING
PERSON
PN
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
4
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures
VIII, LLC
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
3,384,962
(1)
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
3,384,962
(1)
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
OO
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
5
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures
VIII, L.P.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
3,384,962
(1)
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
3,384,962
(1)
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
PN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
6
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures
Fund VIII, L.P.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
3,067,607
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
3,067,607
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,067,607
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
8.4%
|
12
|
|
TYPE OF REPORTING
PERSON
PN
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
7
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures
Fund
VIII-A,
L.P.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
221,197
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
221,197
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
221,197
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
0.61%
|
12
|
|
TYPE OF REPORTING
PERSON
PN
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
8
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
96,158
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
96,158
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
96,158
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
0.26%
|
12
|
|
TYPE OF REPORTING
PERSON
PN
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
9
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Martin P. Sutter
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,842,047
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,842,047
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,842,047
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
10.52%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P., 96,158 shares held by
Essex Woodlands Health Ventures Fund
VIII-B,
L.P. and 457,085 shares held by Essex Woodlands Health Ventures Fund V, L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
10
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Jeff Himawan
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,384,962
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,384,962
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
11
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Ronald W. Eastman
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,384,962
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,384,962
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
12
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Guido J. Neels
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,384,962
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,384,962
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
13
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Petri Vainio
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,384,962
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,384,962
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
14
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Steve Wiggins
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,384,962
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,384,962
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,384,962
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
9.27%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P. and 96,158 shares held
by Essex Woodlands Health Ventures Fund
VIII-B,
L.P.
|
|
|
|
|
|
CUSIP No. 761330109
|
|
|
|
Page
15
of 23 Pages
|
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
Immanuel Thangaraj
|
2
|
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
-0-
|
|
6
|
|
SHARED VOTING POWER
3,842,047
(1)
|
|
7
|
|
SOLE DISPOSITIVE POWER
-0-
|
|
8
|
|
SHARED DISPOSITIVE POWER
3,842,047
(1)
|
|
|
|
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,842,047
(1)
|
10
|
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9)
10.52%
|
12
|
|
TYPE OF REPORTING
PERSON
IN
|
(1)
|
Includes 3,067,607 shares held by Essex Woodlands Health Ventures Fund VIII, L.P., 221,197 shares held by Essex Woodlands Health Ventures Fund
VIII-A,
L.P., 96,158 shares held by
Essex Woodlands Health Ventures Fund
VIII-B,
L.P. and 457,085 shares held by Essex Woodlands Health Ventures Fund V, L.P.
|
ORIGINAL REPORT ON SCHEDULE 13G
Item 1.
|
(a)
|
Name of Issuer: Revance Therapeutics, Inc.
|
|
(b)
|
Address of Issuers Principal Executive Offices:
|
7555 Gateway Boulevard
Newark, California 94560
Item 2.
(a) Name of Person Filing: This Schedule 13G is being filed jointly by Essex Woodlands Health Ventures Fund V, L.P., a Delaware
limited partnership (
Essex V
), Essex Woodlands Health Ventures V, L.L.C., a Delaware limited liability company, the general partner of Essex V (the
Essex V General Partner
), Essex Woodlands Health Ventures Fund
VIII, L.P., a Delaware limited partnership (
Essex VIII
), Essex Woodlands Health Ventures Fund
VIII-A,
L.P., a Delaware limited partnership (
Essex
VIII-A
), Essex Woodlands Health Ventures Fund
VIII-B,
L.P., a Delaware limited partnership (
Essex
VIII-B
, and together with Essex VIII and Essex
VIII-A,
the
Essex VIII Funds
), Essex Woodlands Health Ventures VIII, L.P., a Delaware limited
partnership, the general partner of the Essex VIII Funds (the
Essex VIII Funds GP
), Essex Woodlands Health Ventures VIII, LLC, a Delaware limited liability company, the general partner of the Essex VIII Funds GP (the
Essex VIII General Partner
), Martin P. Sutter, an individual, Jeff Himawan, an individual, Ronald W. Eastman, an individual, Guido J. Neels, an individual, Petri Vainio, an individual, Steve Wiggins, an individual, and Immanuel
Thangaraj, an individual (each a
Manager
, collectively, the
Managers
, and together with the Essex VIII Funds, Essex VIII Funds GP and the Essex VIII General Partner, the
Reporting Persons
).
(b) Address of Principal Business Office: The address of the principal business of each of the Reporting Persons is 21 Waterway Avenue,
Suite 225, The Woodlands, Texas 77380.
(c) Citizenship: Essex V, the Essex VIII Funds and Essex VIII Funds GP are each Delaware limited
partnerships. Essex V General Partner and the Essex VIII General Partner are each Delaware limited liability companies. Each Manager is an individual who is a citizen of the United States.
(d) Title and Class of Securities: Common Stock
(e) CUSIP Number: 761330109
Item 3. If
this statement is filed pursuant to
§§ 240.13d-1(b)
or
240.13d-2(b)
or (c), check whether the person filing is a:
|
|
|
|
|
(a)
|
|
☐
|
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
(b)
|
|
☐
|
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
(c)
|
|
☐
|
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
|
(d)
|
|
☐
|
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a 8).
|
|
|
|
(e)
|
|
☐
|
|
An investment adviser in accordance with
§
240.13d-1(b)(1)(ii)(E);
|
|
|
|
(f)
|
|
☐
|
|
An employee benefit plan or endowment fund in accordance with
§
240.13d-1(b)(1)(ii)(F);
|
|
|
|
(g)
|
|
☐
|
|
A parent holding company or control person in accordance with
§
240.13d-
1(b)(1)(ii)(G);
|
|
|
|
(h)
|
|
☐
|
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
(i)
|
|
☐
|
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a 3);
|
|
|
|
(j)
|
|
☐
|
|
Group, in accordance with
§
240.13d-1(b)(1)(ii)(J).
|
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the Issuer identified in Item 1.
|
(a)
|
Amount Beneficially Owned:
|
For Essex V and Essex V General Partner, 457,085 shares.
For Essex VIII Funds GP and Essex VIII General Partner, 3,384,962 shares.
For Essex VIII, 3,067,607 shares.
For Essex
VIII-A,
221,197 shares.
For Essex
VIII-B,
96,158 shares.
For each of the Managers: Martin P. Sutter and Immanuel Thangaraj, 3,842,047 shares.
For each of the Managers: Jeff Himawan, Ronald W. Eastman, Guido J. Neels, Petri Vainio and Steve Wiggins, 3,384,962 shares.
(b) Percent of Class:
The
following percentages are calculated based on 36,502,409 shares of Common Stock outstanding on December 31, 2017, as set forth in the Issuers Form
10-K
filed with the Securities and Exchange
Commission on March 2, 2018.
For Essex V and Essex V General Partner, 1.25%.
For each of Essex VIII Funds GP and Essex VIII General Partner, 9.27%.
For Essex VIII, 8.40%.
For Essex
VIII-A,
0.61%.
For Essex
VIII-B,
0.26%.
For each of the Managers: Martin P. Sutter and Immanuel Thangaraj, 10.52%.
For each of the Managers: Jeff Himawan, Ronald W. Eastman, Guido J. Neels, Petri Vainio and Steve Wiggins, 9.27%.
|
(c)
|
Number of shares as to which such person has:
|
(i) Sole power to vote or to direct the vote:
For Essex V and Essex V General Partner, 457,085 shares.
For Essex VIII Funds GP and Essex VIII General Partner, 3,384,962 shares.
For Essex VIII, 3,067,607 shares.
For Essex
VIII-A,
221,197 shares.
For Essex
VIII-B,
96,158 shares.
(ii) Shared power to vote or to direct the vote:
For each of the Managers: Martin P. Sutter and Immanuel Thangaraj, 3,842,047 shares.
For each of the Managers: Jeff Himawan, Ronald W. Eastman, Guido J. Neels, Petri Vainio and Steve Wiggins, 3,384,962 shares.
(iii) Sole power to dispose or to direct the disposition of:
For Essex V and Essex V General Partner, 457,085 shares.
For Essex VIII Funds GP and Essex VIII General Partner, 3,842,047 shares.
For Essex VIII, 3,067,607 shares.
For Essex
VIII-A,
221,197 shares.
For Essex
VIII-B,
96,158 shares.
(iv) Shared power to dispose or to direct the disposition of:
For each of the Managers: Martin P. Sutter and Immanuel Thangaraj, 3,842,047 shares.
For each of the Managers: Jeff Himawan, Ronald W. Eastman, Guido J. Neels, Petri Vainio and Steve Wiggins, 3,384,962 shares.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following ☐.
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
N/A
Item 7.
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
N/A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certifications.
N/A
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement
is true, complete and correct.
Date: April 9, 2018
|
|
|
|
|
|
|
ESSEX
WOODLANDS HEALTH VENTURES V, L.L.C.
|
|
|
|
INDIVIDUALS:
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
/s/ Martin P. Sutter
|
|
|
Name: Martin P. Sutter
|
|
|
|
Name: Martin P. Sutter
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND V, L.P.
|
|
|
|
/s/ Jeff Himawan
|
|
|
|
|
|
|
Name: Jeff Himawan
|
By: Essex Woodlands Health Ventures V, L.L.C.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
/s/ Ronald W. Eastman
|
|
|
Title: Managing Director
|
|
|
|
Name: Ronald W. Eastman
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES VIII, LLC
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
/s/ Guido J. Neels
|
|
|
Name: Martin P. Sutter
|
|
|
|
Name: Guido Neels
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES VIII, L.P.
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
|
|
|
|
/s/ Petri Vainio
|
|
|
Its General Partner
|
|
|
|
Name: Petri Vainio
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
/s/ Steve Wiggins
|
|
|
Title: Managing Director
|
|
|
|
Name: Steve Wiggins
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND VIII, L.P.
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, L.P.,
|
|
|
|
/s/ Immanuel Thangaraj
|
|
|
Its General Partner
|
|
|
|
Name: Immanuel Thangaraj
|
|
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
|
|
|
|
|
|
|
Its General Partner
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A, L.P.
|
|
By: Essex Woodlands Health Ventures VIII, L.P.,
|
Its General Partner
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
|
Its General Partner
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
Name: Martin P. Sutter
|
|
|
Title: Managing Director
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND
VIII-B,
L.P.
|
|
By: Essex Woodlands Health Ventures VIII, L.P.,
|
Its General Partner
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
|
Its General Partner
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
Name: Martin P. Sutter
|
|
|
Title: Managing Director
|
|
|
|
Exhibit 1
JOINT FILING AGREEMENT
Each of the undersigned agrees that (i) the statement on Schedule 13G/A relating to the Common Stock of Revance Therapeutics, Inc., has
been adopted and filed on behalf of each of them, (ii) all future amendments to such statement on Schedule 13G/A will, unless written notice to the contrary is delivered as described below, be jointly filed on behalf of each of them, and
(iii) the provisions of Rule
13d-1(k)
under the Securities Exchange Act of 1934 apply to each of them. This agreement may be terminated with respect to the obligations to jointly file future amendments to
such statement on Schedule 13G/A as to any of the undersigned upon such person giving written notice thereof to each of the other persons signature hereto, at the principal office thereof.
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
Date: April 9, 2018.
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES V, L.L.C.
|
|
|
|
INDIVIDUALS:
|
|
|
|
|
|
|
|
|
|
|
/s/ Martin P. Sutter
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
Name: Martin P. Sutter
|
|
|
Name: Martin P. Sutter
|
|
|
|
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND V, L.P.
|
|
|
|
/s/ Jeff Himawan
|
|
|
|
|
Name: Jeff Himawan
|
By: Essex Woodlands Health Ventures V, L.L.C.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
/s/ Ronald W. Eastman
|
|
|
Name: Martin P. Sutter
|
|
|
|
Name: Ronald W. Eastman
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES VIII, LLC
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
/s/ Guido J. Neels
|
|
|
Name: Martin P. Sutter
|
|
|
|
Name: Guido Neels
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES VIII, L.P.
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
|
|
|
|
/s/ Petri Vainio
|
Its General Partner
|
|
|
|
Name: Petri Vainio
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
/s/ Steve Wiggins
|
|
|
Title: Managing Director
|
|
|
|
Name: Steve Wiggins
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND VIII,
|
|
|
|
|
|
|
L.P.
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, L.P.,
|
|
|
|
|
|
|
Its General Partner
|
|
|
|
/s/ Immanuel Thangaraj
|
|
|
|
|
Name: Immanuel Thangaraj
|
By: Essex Woodlands Health Ventures VIII, LLC,
|
|
|
|
|
|
|
Its General Partner
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES FUND
VIII-A,
|
|
|
|
|
|
|
L.P.
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, L.P.,
Its General Partner
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
Its General Partner
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
ESSEX WOODLANDS HEALTH VENTURES
|
|
|
|
|
|
|
FUND
VIII-B,
L.P.
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, L.P.,
Its General Partner
|
|
|
|
|
|
|
|
By: Essex Woodlands Health Ventures VIII, LLC,
Its General Partner
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Martin P. Sutter
|
|
|
|
|
|
|
Name: Martin P. Sutter
|
|
|
|
|
|
|
Title: Managing Director
|
|
|
|
|